• Industry
    • BioValley the Place to be!
    • Excellence in Companies
    • Technology Parks
    • Tech Transfer Opportunities
    • Financial Opportunities
    • BioValley Services
  • Academia
    • BioValley the Place to be!
    • Excellence in Research
    • Tech Transfer Opportunities
    • Financial Opportunities
    • BioValley Services
  • Education
    • Excellence in Education
    • Primary/Secondary Training
  • About the Cluster
    • Who we are?
    • Our Services
    • Our Team
    • INTERREG Program
    • Downloads
    • Contact

Rhenovia Pharma secures Series B funding

By Sibylle | Published: 21 February 2014

RHENOVIA_logo_BDThe company raises EUR 540,000 (USD 738, 000) from historical shareholders to expand its staff Rhenovia, the world leader in biosimulation of the central nervous system, plans to raise a further EUR 2 million in 2014 to step up development in its three key markets of medicinal products, agrifood and neurotoxicity

Read the press release

This entry was posted in Non classé. Bookmark the permalink. Both comments and trackbacks are currently closed.
footer-home footer-contact footer-newsletter
right-footer
  • Site Map
  • Legal Informations